Medical management of herpes simplex ocular infections

International Ophthalmology Clinics

Volumn 36, Issue 2, 1996, Pages 85-97

  Lee, Stephen Y ^a   Laibson, Peter R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

9 (3 HYDROXY 2 PHOSPHONOMETHOXYPROPYL)ADENINE; ACICLOVIR; CIDOFOVIR; IDOXURIDINE; TRIFLURIDINE; VIDARABINE;

ANTIVIRAL ACTIVITY; BLEPHARITIS; DRUG EFFICACY; DRUG USE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; INFECTION RISK; KERATITIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; TOPICAL DRUG ADMINISTRATION; UVEITIS; VIRAL CONJUNCTIVITIS;

EID: 0029902833     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-199603620-00010     Document Type: Review

References (42)

1. Pavan-Langston D. Viral diseases of the cornea and external eye. In: Jakobiec F, Albert D, eds. Principles and practice of ophthalmology. Philadelphia: Saunders 1994:117-161
2. Nahmias A, Roisman B. Infection with herpes simplex viruses I and II (part III). N Engl J Med 1973;289:781
3. Ventura L, Dix R. Viability of herpes simplex virus type 1 on the applanation tonometer. Am J Ophthalmol 1987;103:48
4. Smith I, Peutherer J, MacCallum F. The incidence of herpesvirus hominus antibody in the population. J Hygiene (Camb) 1967;65:395
5. Liesegang T, Melton J III, Daly P, et al. Epidemiology of ocular herpes simplex: incidence in Rochester, Minnesota, 1950 through 1982. Arch Ophthalmol 1989;107:1155
6. Carroll J, Martola EC, Laibson PR, et al. The recurrence of herpetic keratitis following IDU therapy. Am J Ophthalmol 1967;63:103-107
7. Schuster J, Kaufman H, Nesburn A. Statistical analysis of the rate of recurrence of herpes virus ocular epithelial disease. Am J Ophthalmol 1981;91:328
8. US Department of Health and Human Services. External ocular infections and inflammatory disease. In: Vision research: a national plan 1983-1987 (NIH publication no. 83-2472). Washington, DC: National Eye Institute, 1983
9. Pavan-Langston D. Viral diseases: herpetic infections. In: Smolin G, Thoft R, eds. Cornea, ed 3. Boston: Little, Brown, 1993:240
10. Whitley R, Nahmias A, Visintine A, et al. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics 1980;4:489
11. Azazi M, Gunilla M, Forsgren M. Late ophthalmologic manifestations of neonatal herpes simplex virus infection. Am J Ophthalmol 1990;109:1
12. Pavan-Langston D, Rong B, Dunkel E. Extraneural herpetic latency: animal and human corneal studies. Acta Ophthalmol Suppl 1989;192:135
13. Spear P. Glycoproteins specified by herpes simplex viruses. In: Roizman B, ed. The herpesviruses, vol 3. New York: Plenum, 1985:315
14. Kaufman H, Centifanto-Fitzgerald Y, Varnell E. Herpes simplex keratitis. Ophthalmology 1983;90:700
15. Kaufman H, Varnell E, Centifanto Y, et al. Effect of herpes simplex virus genome on the response of infection to steroids. Am J Ophthalmol 1985;100:114
16. Egerer U-D, Stary A. Erosive-ulcerative herpes simplex blepharitis. Arch Ophthalmol 1980;98:1760
17. Spruance S, Stewart J, Rowe N, et al. Treatment of recurrent herpes simplex labialis with oral acyclovir. J Infect Dis 1990;161:185
18. Wilhelmus KR, Coster DJ, Jones BR, Prognostic indicators of herpetic keratitis. Arch Ophthalmol 1981;99:1578
19. Tullo AB. Isolation of herpes simplex virus from corneal discs of patients with chronic stromal keratitis. In: Maudgal PC, Missoten L, eds. Documenta ophthalmologica proceedings: herpetic eye diseases, series 44. Dordrecht, Netherlands: Dr. W. Junk Publishers, 1985:57
20. Wilhelmus KR, Gee L, Hauck WW, et al. Herpetic eye disease study: a controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology 1994;101:1883
21. Cohen E, Laibson P, Arentson J. Corneal transplantation for herpes simplex keratitis. Am J Ophthalmol 1983;95:645
22. McEvoy GK. Acyclovir. In: American Society of Health System Pharmacists drug information. Bethesda, MD: 1990:353
23. Schaffer HJ. Acyclovir chemistry and spectrum of activity. Am J Med 1982;73:4
24. Elion GB. Mechanism of action and selectivity of acyclovir. Am J Med 1982;73:7
25. Hung SO, Patterson A, Rees PJ. Oral acyclovir in the management of dendritic herpetic corneal ulceration. Br J Ophthalmol 1984;68:398
26. Pavan-Langston D. Herpetic keratitis: inhibition of epithelial recurrences with longterm oral acyclovir. In: Proceedings of the New England Ophthalmological Meeting October 21, 1992
27. Barron B, Gee L, Hauck WW, et al. Herpetic eye disease study: a controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology 1994;101:1871
28. Epstein RJ, Seedor JA, Dreizen NG, et al. Penetrating keratoplasty for herpes simplex keratitis and keratoconus. Ophthalmology 1987;94:935
29. Kok van Alphen CG, Volker-Dieben JM. Prevention and treatment of herpes recurrence in the corneal graft with acyclovir. In: Maudgal PC, Missoten L, eds. Documenta ophthalmologica proceedings: herpetic eye diseases, series 44. Dordrecht, Netherlands: Dr. W. Junk Publishers, 1985:319
30. Beyer CF, Arens MQ, Hill GA, et al. Oral acyclovir reduces the incidence of recurrent herpes simplex keratitis in rabbits after penetrating keratoplasty. Arch Ophthalmol 1989;107:1200
31. Barney N, Foster CS. A prospective randomized trial of oral acyclovir following penetrating keratoplasty for herpes. Cornea 1994;13:232
32. Fardeau G, Langlois M, Mathys B, et al. Emergence of cross-resistant herpes simplex virus following topical drug therapy in rabbit keratitis. Curr Eye Res 1991;10(suppl):151
33. Fardeau C, Langlois M, Nugier F, et al. Cross-resistances to antiviral drugs of IUDR-resistant HSV1 rabbit keratitis and in vitro. Cornea 1993;12:19
34. Maudgal PC, Clercq ED. (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl) cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis. Invest Ophthalmol Vis Sci 1991;32:1816
35. Aoki H, Akaike T, Abe K, et al. Antiviral effect of oryzacystatin, a proteinase inhibitor in rice, against herpes simplex virus type 1 in vitro and in vivo. Antimicrob Agents Chemother 1995;39:846
36. Staats HF, Oakes JE, Lausch RN. Anti-glycoprotein D monoclonal antibody protects against herpes simplex virus type 1-induced diseases in mice functionally depleted of selected T-cell subsets of asialo GM1 + cells. J Virol 1991;65:6008
37. Inoue Y, Oh JO, Minasi P. Protective effect of anti-glycoprotein D antibody on herpetic chorioretinitis in newborn rabbits. Curr Eye Res 1991;10(suppl):159
38. Colin J, Malet F, Chastel C, Richard MC. Use of collagen shields in the treatment of herpetic keratitis. Curr Eye Res 1991;10(suppl):189
39. Willey DE, Williams I, Faucett C, Openshaw H, Ocular acyclovir delivery by collagen discs: a mouse model to screen anti-viral agents. Curr Eye Res 1991;10(suppl):167
40. Naito T, Nitta K, Kinouchi Y, et al. Effects of 9-(1,3-dihydroxy-2-propoxymethyl) guanine (DHPG) eye drops and cyclosporine eye drops in the treatment of herpetic stromal keratitis in rabbits. Curr Eye Res 1991;10(suppl):201
41. Taylor JL, Punda-Polic V, O'Brien WJ. Combined anti-herpes virus activity of nucleoside analogs and interferon. Curr Eye Res 1991;10(suppl):205
42. Klager AJ, Bucht ER, Osusky R, et al. Topical immunoglobulins for epithelial herpes simplex keratitis. Ophthalmologica 1993;207:78